1.
Belinostat in relapsed/refractory peripheral T-cell lymphoma: A real-world multicenter experience. Ann Med Res [Internet]. 2026 Apr. 24 [cited 2026 May 11];33(4):178-84. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4910